INTRODUCTION
Summary: Reconstruction of maxilla defects has remained one of the most challenging problems in craniomaxillofacial reconstruction because it typically requires harvesting and grafting of autologous bone, which poses limitations related to the difficulties in accurately reconstructing the defected bone and the highly prolonged duration of surgery. We employed tissue-engineered, patient-specific, 3-dimensional (3D)-printed biodegradable scaffolds for maxillofacial bone reconstruction in patients with complex maxillary defects after surgical removal of cancer. A customized polycaprolactone (PCL) scaffold was designed and fabricated for each patient. For this purpose, we used computer-aided design and manufacturing combined with 3D printing technology. The patients implanted with the PCL scaffolds were followed up for up to 2 years with careful evaluation of morphological changes in the face. We confirmed that the patient-specific 3D-printed PCL scaffold effectively filled the maxillary defect and promoted regeneration of the deficient tissue while remaining stable in the body for a relatively long period. Employing customized tissueengineered scaffolds built using the patient's computed tomography data and an extrusion-based 3D printing system is safe and clinically feasible, helping create and maintain improved morphological features of the face, which represents the most important aspect from the perspective of the patients. which substantially increases the risk of inflammation, infection, and even implant protrusion. 8, 9 To address these limitations, current efforts aim to facilitate regeneration or reconstruction of the defect area using 3D-printed scaffolds made of biodegradable and clinically safe polymers.
Recently, 3D-printed, patient-tailored splints made of the biocompatible and biodegradable polymer polycaprolactone (PCL) were used to prevent airway stenosis in infants with tracheobronchomalacia. 10, 11 In this context, we describe the fabrication and implantation of patient-specific, 3D-printed PCL scaffolds with fully interconnected pores for complicated craniomaxillofacial reconstruction.
PATIENTS AND METHODS

Patient Characteristics
Patient 1 was a 43-year-old woman who had undergone left radial maxillectomy for minor salivary cancer in the left maxillary sinus and hard palate, with immediate reconstruction using a fibular osteocutaneous free flap. Patient 2 was a 45-year-old man who had been diagnosed with squamous cell carcinomas in the left maxillary sinus 8 years before presenting to our department. The patient had undergone radical maxillectomy and partial mandibulectomy, which resulted in severe facial deformity. Patient 3 was an 18-year-old man who had received right partial maxillectomy for chondrosarcoma 9 years before presenting to our department; the procedure had resulted in a medial maxilla defect on the right side of the face.
This study was approved by the Institutional Review Board and Ethics Committee of our center (approval No. KC14DNME0751). The 3D-printed scaffold was manufactured according to Good Manufacturing Practice provisions [registration No. KTC-ABB-170177, approved by the South Korea Ministry of Food and Drug Safety (MFDS) and was registered as a medical device in South Korea (registration No. 14-1337, approved by the MFDS].
Designing the Customized Scaffolds
Customized PCL scaffolds were designed using commercial 3D medical image editing software (Materialise Mimics; Materialise NV, Leuven, Belgium). The patient's head was scanned using a computed tomography (CT) device, with a slice thickness of 1 mm. The side with the normal bony orbit was mirrored to the midsagittal plane, which was defined according to standardized bony landmarks (see figure, Supplemental Digital Content 1, which demonstrates designing the customized implant, http:// links.lww.com/PRSGO/A906). Finally, patient-specific scaffolds were fabricated using a 3D-printing system (Fig. 1A) .
Fabrication of 3D-printed PCL Scaffolds
For use as tissue-regeneration scaffolds, fully customized scaffolds made of medical-grade PCL (Evonik Industries, Essen, Germany) were fabricated using the in-house 3D printer. 12, 13 This process was performed in 
Surgical Procedures
The PCL scaffold customized for each patient was inserted under general anesthesia. The maxillary defect was exposed through a simple incision. The implant was inserted, and the incision was closed without using an additional flap or tissue transfer (see video, Supplemental Digital Content 2, which demonstrates the surgical process for Patient 3. This video is available in the "Related Videos" section at PRSGlobalOpen.com or at http://links. lww.com/PRSGO/A907).
CT Image Analysis
The follow-up CT data were converted into 2D-or 3Dreconstructed images. The pre-and postoperative 3D images were overlapped to analyze the increase in soft-tissue volume after surgery.
Statistical Analysis
The difference between mean values was evaluated using Student's t test, in which a P value < 0.01 was considered to indicate significance.
RESULTS
Clinical Outcomes
The implanted scaffolds were well maintained during follow-up, without the occurrence of any complications, such as wound dehiscence or infection. Eye height with an acceptable degree of symmetry (compared with that noted preoperatively) was maintained throughout the follow-up period (Fig. 1B) . The presence of neo-tissue ingrowth can be seen in Supplemen 
CT-based Quantitative Analysis after Reconstruction
Overlapping the pre-and postoperative CT images revealed that reconstructive surgery achieved an increase of 2,711 mm 3 in patient 1 at 16 months postoperatively (Fig. 1C ). Measurement of Hounsfield unit values on CT images indicated that, tissue density (ie, the HU values) in the area where the scaffold was implanted increased significantly. In the preoperative state, the mean HU value was ˗76.269. After scaffold implantation, the HU values at 6 and 16 months postoperatively were 63.7825 and 73.0488, respectively.
DISCUSSION
By adjusting the parameters of the 3D printing-based fabrication method, the customized scaffolds can be designed to have thoroughly interconnected 3D pores. In the present study, the scaffolds were fabricated with a reference pore size of 900 μm to promote tissue ingrowth. Follow-up evaluation revealed that the pores had indeed become filled with soft tissue, and the facial contour was well maintained. Considering that no signs of infection were observed in any of the patients after scaffold implantation, we believe that fusion with existing native tissue occurred successfully due to early vascularization and tissue filling within the pores.
PCL scaffolds, which have a degradation period of 2-3 years, are suitable for use as biocompatible tissue-engineered scaffolds and the induction of tissue regeneration, although they have a limited capacity to induce bone tissue ingrowth. [14] [15] [16] Indeed, our CT-based analysis revealed increased tissue density, thus confirming soft-tissue ingrowth. It did not, however, indicate that bone tissue had regenerated within the PCL scaffold. To promote bone tissue regeneration, future studies should consider using a different material, such as blended PCL/beta-tricalcium phosphate (powder type) with an adequate pore size and seeding of relevant cells. 13, 17, 18 
CONCLUSIONS
Complicated craniomaxillofacial defects can be reconstructed efficiently using 3D-printed, patient-specific scaffolds. We reported that customized, tissue-engineered scaffolds could be successfully fabricated using the patients' CT data and an extrusion-based 3D printing system. Moreover, biodegradable PCL polymer promoted regeneration of deficient tissue while remaining stable in the body for a relatively extended period.
